The Genomic Revolution is A Live at The New Methodist Hospital Houston
Genomics is marking a mark in Houston speaking with Kelly J. Maresh RN, MBA ACRP 2012
Global Conference Houston. The Methodist Hospital Research Institute has identified more than 500 genes that may cause or contribute to the development of pancreatic cancer. This particularly deadly disease has a 1-in-20 survival rate after five years, largely because no effective genetic screening method exists for early detection.
Principal investigators Nancy Jenkins, Ph.D., and Neal Copeland, Ph.D., report in
ftPJhe Proceedings of the National Academy of Sciences, that the vast majority of the 543 genes they identify in mouse models have identical or highly similar versions in humans, and that 20 of those equivalent genes were found to be strongly associated with poor survival in human pancreatic cancer patients.
"Knowing what genes are involved in the development of pancreatic cancer, as well as what those genes' functions are and how they influence signaling pathways, will be crucial to the development of new drugs and other therapies," said Copeland, director of The Methodist Hospital Research Institute Cancer Research Program and a National Academy of Sciences fellow.
A success story at Methodist Hospital Houston is The Methodist Academy. The Methodist Academy is a scholarly partnership between The Methodist Hospital Research Institute, Weill Cornell Medical College, and the Weill Cornell Graduate School of Medical Sciences of Cornell University. It is governed by the Council of Deans, which includes members of the Institute of Medicine, National Academy of Science, and National Academy of Engineers.
The purpose of The Methodist Academy is to develop educational and research partnerships that foster medical innovation. These partnerships will expand to include additional partner institutions and train students and postdoctoral researchers to be leaders of medicine by identifying clinically relevant challenges, and developing research programs that translate into technological advances in the clinic.
ACRP 2012 has the worlds Best Group Of Clinical Research Organization Collaborating, Networking using Genomic Science. GenNXeix Biotech has agreed to Join ACRP
No comments:
Post a Comment